Mancini Anthony Insider Trades & Stock Holdings

Chief Global Commercialization Officer · Revolution Medicines, Inc. · Latest filing Sep 25, 2026

Mancini Anthony, Chief Global Commercialization Officer at Revolution Medicines, Inc. has 4 Form 4 trades on file since Sep 16, 2026. Open-market activity: 0 purchases ($0) and 4 sales ($1.44M), net -$1.44M. Latest filing: disposed of 3.12K shares of $RVMD on Sep 25, 2026 at $200.54.

Trades on file

4

Open-market bought

$0

Open-market sold

$1.44M

Net open-market

-$1.44M

Latest filing

Sep 25, 2026

All insider trades by Mancini Anthony

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 25, 2026	$RVMD	Sell (Open-market sale) 10b5-1	3.12K	$200.54	$625.89K			+0.8%			Chief Global Commercialization Officer		—
Sep 24, 2026	$RVMD	Sell (Open-market sale) 10b5-1	587	$200	$117.40K			+3.0%			Chief Global Commercialization Officer		—
Sep 18, 2026	$RVMD	Sell (Open-market sale) 10b5-1	1.76K	$196.94	$347.40K			+7.3%			Chief Global Commercialization Officer		—
Sep 16, 2026	$RVMD	Sell (Open-market sale) 10b5-1	1.77K	$199.24	$353.45K			-2.6%	-9.2%		Chief Global Commercialization Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Mancini Anthony traded

• $RVMD

Frequently asked questions

Has Mancini Anthony been buying or selling stock?

Mancini Anthony has 0 open-market purchases and 4 open-market sales on file, net -$1.44M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Mancini Anthony's latest insider trade?

disposed of 3.12K shares of $RVMD on Sep 25, 2026 at $200.54.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.